ENCell

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

encellinc.com

Country

South Korea

Exchange

KOSDAQ

Founded 2018

ENCell develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease Contracting development and manufacturing services for biopharmaceutical products. Founded in 2018, the company is based in Seoul, South Korea.

Key Stats

52-Week Range

₩5000.00₩20950.00

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.